Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17916806 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tiotropium bromide 18mcg;   Drug: Fluticasone propionate/ salmeterol combination 50/500mcg

Study has passed its completion date and status has not been verified in more than two years.